Clinical Trial Update: Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating perioperative tranexamic acid use in bone tumor surgery for Ewing sarcoma of bone and osteosarcoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma of Bone
• Osteosarcoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Children's Cancer Hospital Egypt 57357 | Conditions: Ewing Sarcoma of Bone, Osteosarcoma | Phase 3 | Status: COMPLETED